Essex Medipharma to Distribute Pfizer Glaucoma Eye Drops in China

Essex Medipharma, a subsidiary of Essex Bio-Technology, signed an agreement with Pfizer to be the exclusive importer and distributor for two types of Pfizer eye drops in China. Xalatan® and Xalacom® eye drops both treat the high intraocular fluid pressure associated with glaucoma. The agreement between Essex and Pfizer has a term of five years, with an automatic extension of three years, unless either party decides to end the relationship. More details.... Stock Symbols: (HK: 1061) (NYSE: PFE) Share this with colleagues: // //